Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol vs Pirfenidone in Peritoneal Carcinomatosis
NCT07856914Phase 2Not yet recruiting
- Start
- Sep 2026
- Primary completion
- Sep 2030
01
Overview
A Phase 2 trial of paricalcitol oral solution, pirfenidone in peritoneal carcinomatosis (PC). Planned start Sep 2026; status: not yet recruiting.
02
Drugs
paricalcitol oral solutionpirfenidone
03
Conditions
peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT07856914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07856914.